[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:st2-gene":3},{"name":4,"total":5,"recruiting":6,"trials":7},"ST2 Gene",3,2,[8,16,22],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05661201","NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors",[12],"Phase 1","RECRUITING","2026-08-26T02:17:42.501124Z","2026-05-05T02:43:26.768897Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT07025538","Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation",[12],"2026-08-26T02:16:34.792807Z","2026-04-29T02:57:57.116813Z",{"nct_id":23,"title":24,"phases":25,"status":26,"updated_at":27,"content_modified":28},"NCT04365179","Study of NEROFE, a Novel Hormone-Peptide in Adult Patients With Advanced MDS and AML",[12],"UNKNOWN","2026-08-03T02:22:03.670928Z","2026-05-05T02:43:26.922696Z"]